Purpose: Living with a melanoma diagnosis can be challenging. We aimed to assess the feasibility, acceptability, and perceived value of a nurse-led intervention that utilised patient-reported outcome (PRO) measures to identify and address the supportive care needs of newly diagnosed patients with Stage I/II melanoma over the first 4 months post-diagnosis. Methods: We conducted an exploratory, repeated-measures, single-arm, feasibility trial. One baseline (4 weeks post-diagnosis; T1) and one follow-up intervention session (4 weeks after wide local excision; T3) took place, two months apart. Patient survey data were collected monthly, at four assessment points (T1-T4), followed by exit interviews. Results: A recruitment rate of 55...
BACKGROUND: Melanoma is common with increasing incidence. Guidelines recommend monthly total skin se...
Introduction: Logistics pertinent to the use of patient-reported outcome measures (PROMs) by Colorec...
BACKGROUND: Melanoma incidence has quadrupled since 1970 and melanoma is now the second most common ...
Purpose: Living with a melanoma diagnosis can be challenging. We aimed to assess the feasibility, ...
Purpose: Understanding the supportive care and unmet care needs of patients with melanoma is essenti...
With increased survival among patients with metastatic melanoma and limited time with health care pr...
Purpose: People with advanced melanoma face an uncertain trajectory as new treatments now have the p...
BACKGROUND: Despite a good prognosis for most melanoma survivors, many experience substantial fear o...
Background: New advanced melanoma therapies are associated with improved survival; however, quality ...
BACKGROUND: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and inc...
Purpose: Our goal is to evaluate the effectiveness of an individualized educational session by a nu...
Background: Despite a good prognosis for most melanoma survivors, many experience substantial fear o...
Objectives To identify patient-reported outcome measures (PROMs) and patient-reported experience mea...
Background: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and inc...
Purpose - We aimed to describe variations in unmet supportive care needs of patients diagnosed with ...
BACKGROUND: Melanoma is common with increasing incidence. Guidelines recommend monthly total skin se...
Introduction: Logistics pertinent to the use of patient-reported outcome measures (PROMs) by Colorec...
BACKGROUND: Melanoma incidence has quadrupled since 1970 and melanoma is now the second most common ...
Purpose: Living with a melanoma diagnosis can be challenging. We aimed to assess the feasibility, ...
Purpose: Understanding the supportive care and unmet care needs of patients with melanoma is essenti...
With increased survival among patients with metastatic melanoma and limited time with health care pr...
Purpose: People with advanced melanoma face an uncertain trajectory as new treatments now have the p...
BACKGROUND: Despite a good prognosis for most melanoma survivors, many experience substantial fear o...
Background: New advanced melanoma therapies are associated with improved survival; however, quality ...
BACKGROUND: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and inc...
Purpose: Our goal is to evaluate the effectiveness of an individualized educational session by a nu...
Background: Despite a good prognosis for most melanoma survivors, many experience substantial fear o...
Objectives To identify patient-reported outcome measures (PROMs) and patient-reported experience mea...
Background: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and inc...
Purpose - We aimed to describe variations in unmet supportive care needs of patients diagnosed with ...
BACKGROUND: Melanoma is common with increasing incidence. Guidelines recommend monthly total skin se...
Introduction: Logistics pertinent to the use of patient-reported outcome measures (PROMs) by Colorec...
BACKGROUND: Melanoma incidence has quadrupled since 1970 and melanoma is now the second most common ...